The Anderson Perspective

Treace Medical heads to the J.P. Morgan conference to showcase its surgical tech, facing tough questions on growth amid competition and market shifts.

Behind NASA's return to the Moon, private contractors perform critical launch rehearsals, ensuring the safety of the first crewed lunar flight in 50 years.

OWC is set to debut a suite of next-gen Thunderbolt 5 hardware and a disruptive software platform, promising to supercharge creative workflows.

Diamyd Medical's pivotal Phase 3 trial gets a nine-month acceleration, raising hopes for a new precision therapy that preserves insulin production.

A new class action lawsuit accuses medical device firm Integer Holdings of hiding poor sales while touting growth, leading to a major stock drop.

The powerboat giant expands its share repurchase in a show of financial strength, betting on long-term recovery despite a soft recreational market.

Amid rising legal threats, a new coalition offers free legal aid to Canadian journalists, aiming to protect press freedom and empower local reporting.

A new tech platform is giving homeowners a verified voice, using a "Trust Index" to rate HOAs and disrupt the $11 trillion community housing market.

New Measure A funds will provide emergency rental aid to thousands of at-risk households, marking a major step in the county's new housing strategy.

A strategic investment from a defense-focused fund aims to accelerate LEAP's responsive launch systems, signaling a new era for U.S. space superiority.

As AI and cloud sprawl create new risks, Radiant Logic’s award-winning Identity Data Fabric is hailed as a key innovation for enterprise security.

AI firm Itemize's AWS Marketplace debut, via a Labra partnership, signals a major shift in how banks adopt automation to cut costs and streamline work.

After bombshell allegations and a stock plunge, Rezolve AI faces a major lawsuit investigation, raising critical questions about AI hype and corporate honesty.

An Indiana biotech prepares for biotech's biggest stage, showcasing a pipeline that offers new hope for chronic endocrine and metabolic disorders.

Acadia's new powder form of the only Rett syndrome drug offers families vital choice, easing daily care and showing the power of patient-led innovation.

With a landmark SEC nod, DTCC is set to tokenize major assets. Discover how this move bridges traditional and digital finance for a more efficient future.

Bill Ackman's fund posted a stellar 24.1% return. We dive into the high-conviction plays and innovative structure driving this market-beating performance.

A new pact on quantum computing and AI safety aims to do more than innovate—it seeks to build a secure, equitable digital world for every citizen.

Canada adds four groups to its terror list, taking a bold stand against online networks preying on youth and global insurgencies. Here's what it means.

Bill Ackman's fund is buying back its own shares at a deep discount. We explore the innovative financial strategy and its impact on shareholder value.